Shareholders Equity: The sum of preferred and common equity items.
Oramed Pharmaceuticals Inc. (ORMP) had Shareholders Equity of $202.33M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$48.40M |
|
-- |
|
-- |
|
$2.43M |
|
$-2.43M |
|
$61.88M |
|
$59.45M |
|
$59.45M |
|
$48.39M |
|
$48.39M |
|
$48.39M |
|
$48.39M |
|
$-2.43M |
|
$-2.40M |
|
41.76M |
|
42.77M |
|
$1.16 |
|
$1.13 |
|
| Balance Sheet Financials | |
$136.12M |
|
$0.61M |
|
$84.38M |
|
$220.49M |
|
$6.12M |
|
-- |
|
$12.04M |
|
$18.16M |
|
$202.33M |
|
$202.33M |
|
|
Shareholders Equity |
$202.33M |
40.84M |
|
| Cash Flow Statement Financials | |
$-8.68M |
|
$7.13M |
|
$-0.73M |
|
$54.42M |
|
$52.18M |
|
$-2.24M |
|
$3.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
23.92% |
|
23.92% |
|
21.95% |
|
23.92% |
|
$4.95 |
|
$-0.20 |
|
$-0.20 |
|